Novartis
NVS
#59
Rank
โ‚ฌ247.80 B
Marketcap
130,38ย โ‚ฌ
Share price
-0.55%
Change (1 day)
25.03%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Market capitalization of Novartis (NVS)

Market cap: โ‚ฌ247.80 Billion

As of August 2026 Novartis has a market cap of โ‚ฌ247.80 Billion. This makes Novartis the world's 59th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novartis from 1998 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ247.80 B9%
2025โ‚ฌ227.33 B20.26%
2024โ‚ฌ189.03 B0.69%
2023โ‚ฌ187.74 B3.2%
2022โ‚ฌ181.91 B4.86%
2021โ‚ฌ173.48 B-2.02%
2020โ‚ฌ177.05 B-7.68%
2019โ‚ฌ191.77 B11.21%
2018โ‚ฌ172.44 B4.93%
2017โ‚ฌ164.34 B-0.07%
2016โ‚ฌ164.45 B-13.74%
2015โ‚ฌ190.65 B3.51%
2014โ‚ฌ184.19 B30.69%
2013โ‚ฌ140.94 B22.39%
2012โ‚ฌ115.16 B8.3%
2011โ‚ฌ106.33 B5.09%
2010โ‚ฌ101.18 B15.94%
2009โ‚ฌ87.27 B8.26%
2008โ‚ฌ80.61 B-4.29%
2007โ‚ฌ84.22 B-17.6%
2006โ‚ฌ102.22 B-1.22%
2005โ‚ฌ103.48 B14.45%
2004โ‚ฌ90.41 B0.52%
2003โ‚ฌ89.94 B3.43%
2002โ‚ฌ86.96 B-17.43%
2001โ‚ฌ105.31 B-14.95%
2000โ‚ฌ123.82 B29.61%
1999โ‚ฌ95.53 B-15.54%
1998โ‚ฌ113.10 B

End of Day market cap according to different sources

On Aug 14th, 2026 the market cap of Novartis was reported to be:

โ‚ฌ248.80 Billion
by Nasdaq info icon info icon
โ‚ฌ247.80 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ542.15 B 118.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ131.94 B-46.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ167.44 B-32.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ90.52 B-63.47%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ289.59 B 16.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ112.66 B-54.53%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ209.66 B-15.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ85.70 B-65.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ37.02 B-85.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel